Search research articles
Contact Us
Filters
Showing results (1291-1300 of 1,779) with videos related to
Page
of 178
Sort By:
Mabs
|
May 25, 2019
De novo discovery of antibody drugs - great promise demands scrutiny
William J J Finlay, Alexey A Lugovskoy
Mabs
|
August 6, 2019
Process intensification in fed-batch production bioreactors using non-perfusion seed cultures
Andrew Yongky, Jianlin Xu, Jun Tian, et al.
Mabs
|
June 23, 2022
Engineering death resistance in CHO cells for improved perfusion culture
Michael A MacDonald, Matthias Nöbel, Verónica S Martínez, et al.
Mabs
|
June 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variants
Tatjana Sela, Tamara Wirth, Annika Sommer, et al.
Mabs
|
July 15, 2026
Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry
Elizabeth Hecht, Esther Martin, Idlir Liko, et al.
Mabs
|
June 30, 2022
Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment
Christopher Negron, Joyce Fang, Michael J McPherson, et al.
Mabs
|
October 7, 2020
Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human <i>FCGRT</i> transgenic mice
Benjamin E Low, Gregory J Christianson, Emily Lowell, et al.
Mabs
|
December 15, 2020
Identification and quantitation of hinge cysteinylation on endogenous IgG2 antibodies from human serum
Luladey Ayalew, Alicia D D'Souza, Yan Chen, et al.
Mabs
|
June 14, 2022
A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies
Sebastiaan C de Graaf, Max Hoek, Sem Tamara, et al.
Mabs
|
June 14, 2022
<i>In vitro</i> discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom
Line Ledsgaard, Andreas H Laustsen, Urska Pus, et al.
Page
of 178
Search research articles
Search
Showing results (1291-1300 of 1,779) with videos related to
Sort By:
Page
of 178
Mabs
|
May 25, 2019
De novo discovery of antibody drugs - great promise demands scrutiny
William J J Finlay, Alexey A Lugovskoy
Mabs
|
August 6, 2019
Process intensification in fed-batch production bioreactors using non-perfusion seed cultures
Andrew Yongky, Jianlin Xu, Jun Tian, et al.
Mabs
|
June 23, 2022
Engineering death resistance in CHO cells for improved perfusion culture
Michael A MacDonald, Matthias Nöbel, Verónica S Martínez, et al.
Mabs
|
June 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variants
Tatjana Sela, Tamara Wirth, Annika Sommer, et al.
Mabs
|
July 15, 2026
Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry
Elizabeth Hecht, Esther Martin, Idlir Liko, et al.
Mabs
|
June 30, 2022
Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment
Christopher Negron, Joyce Fang, Michael J McPherson, et al.
Mabs
|
October 7, 2020
Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human <i>FCGRT</i> transgenic mice
Benjamin E Low, Gregory J Christianson, Emily Lowell, et al.
Mabs
|
December 15, 2020
Identification and quantitation of hinge cysteinylation on endogenous IgG2 antibodies from human serum
Luladey Ayalew, Alicia D D'Souza, Yan Chen, et al.
Mabs
|
June 14, 2022
A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies
Sebastiaan C de Graaf, Max Hoek, Sem Tamara, et al.
Mabs
|
June 14, 2022
<i>In vitro</i> discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom
Line Ledsgaard, Andreas H Laustsen, Urska Pus, et al.
Page
of 178